Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.420
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
1.420
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Akebia Therapeutics Employees
Akebia Therapeutics had 194 employees as of December 31, 2025. The number of employees increased by 13 or 7.18% compared to the previous year.
Employees
194
Change (1Y)
13
Growth (1Y)
7.18%
Revenue / Employee
$1,217,505
Profits / Employee
-$27,552
Market Cap
380.42M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 334 |
| Esperion Therapeutics | 294 |
| Anika Therapeutics | 235 |
| Aquestive Therapeutics | 147 |
AKBA News
- 15 days ago - Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090 - GlobeNewsWire
- 21 days ago - Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium - GlobeNewsWire
- 26 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Akebia Therapeutics Transcript: R&D Day 2026 - Transcripts
- 27 days ago - Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026 - GlobeNewsWire
- 7 weeks ago - Akebia Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire